Table 14:
Number of Studies (Design) | Risk of Bias | Inconsistency | Indirectness | Imprecision | Publication Bias | Upgrade Considerations | Quality |
---|---|---|---|---|---|---|---|
Compared With Sham | |||||||
1 (RCT)38 | No serious limitations | No serious limitationsa | No serious limitations | No serious limitationsb | Undetecteda | NA | ⊕⊕⊕⊕ High |
Compared With Deep Brain Stimulation | |||||||
1 (Observational)40 | Serious limitations (−1)c | No serious limitationsa | No serious limitations | Serious limitations (−1)d | Undetecteda | NA | ⊕ Very Low |
MRgFUS Only | |||||||
3 (Observational)37,42,45 | No serious limitationse | No serious limitationsa | No serious limitations | No serious limitationsf | Undetecteda | NA | ⊕⊕ Low |
Abbreviations: MRgFUS, magnetic resonance-guided focused ultrasound; NA, not applicable; RCT, randomized controlled trial.
Cannot definitively assess presence or absence because the evidence is derived from a single study.
Absolute change and relative improvement are both clinically meaningful and statistically significant.
Risk of bias was highest owing to retrospective data collection methods. The full risk-of-bias assessment is presented in Appendix 2, Table A2.
Considerable imbalance in group sizes for comparisons, optimal information size criteria not met, no measures of variance or confidence intervals provided; therefore, uncertainty remains in the precision of estimates.
Risk of bias judged to be low for all considerations except participant selection, which was unclear. The full risk-of-bias assessment is presented in Appendix 2, Table A2.
Statistical power an issue in one study; however, a clinically meaningful and statistically significant, large effect was found.